Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04903028 · ClinicalTrials.gov registry record · NA

RTMS Targets Neural Circuits for Smoking Cessation

A NA study of Tobacco Use and Cigarette Smoking, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
64
Enrollment target
2
Study locations

NCT04903028 is a NA study of Tobacco Use and Cigarette Smoking that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 64 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04903028, a NA study of Tobacco Use and Cigarette Smoking, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
64 participants
Enrollment target
2
Study locations

Study Summary

Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, investigators will use brain MRI to guide TMS therapy for smoking cessation.

Interventions

  • DEVICE Sham rTMS
  • DEVICE Active rTMS 10 Hz DLPFC

Study Locations (2)

South Carolina

  • Medical University of South Carolina - Charleston
  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2021-05-15
Est. Completion 2027-04-04
Phase NA

What the Registry Record Tells You About NCT04903028

The ClinicalTrials.gov registry entry for NCT04903028 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (83% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Sham rTMS is the first listed.

NCT04903028 reports 2 study locations spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT04903028 about?

NCT04903028 is a clinical study titled "RTMS Targets Neural Circuits for Smoking Cessation". Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, in...

What is the current status of trial NCT04903028?

This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2021-05-15. Estimated completion is 2027-04-04.

What conditions does trial NCT04903028 study?

This clinical trial studies the following conditions: Tobacco Use, Cigarette Smoking.

What interventions are being tested in trial NCT04903028?

The interventions under investigation include: Sham rTMS (DEVICE), Active rTMS 10 Hz DLPFC (DEVICE).

Who is sponsoring clinical trial NCT04903028?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04903028 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.